Ars Pharmaceuticals logo

Ars Pharmaceuticals Share Price Today

(NASDAQ: SPRY)

Ars Pharmaceuticals share price is $11.53 & ₹1,005.50 as on 12 Mar 2025, 19.44 hrs IST

$11.53

0.7

(6.46%)

Market is closed - opens 7 PM, 12 Mar 2025

View live Ars Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ars Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ars Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Ars Pharmaceuticals share price movements

  • Today's Low: $10.70
    Today's High: $11.62

    Day's Volatility :7.92%

  • 52 Weeks Low: $7.55
    52 Weeks High: $18.51

    52 Weeks Volatility :59.21%

Ars Pharmaceuticals (SPRY) Returns

PeriodArs Pharmaceuticals IncIndex (Russel 2000)
3 Months
-6.03%
0.0%
6 Months
-3.92%
0.0%
1 Year
36.29%
0.0%
3 Years
220.28%
-10.6%

Ars Pharmaceuticals (SPRY) Key Statistics

in dollars & INR

Previous Close
$11.53
Open
$10.8
Today's High
$12.05
Today's Low
$11.68
Market Capitalization
$1.1B
Today's Volume
$1.2M
52 Week High
$18.51
52 Week Low
$7.55
Revenue TTM
$2.6M
EBITDA
$-60.4M
Earnings Per Share (EPS)
$-0.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22.41%

How to invest in Ars Pharmaceuticals Stock (SPRY) from India?

It is very easy for Indian residents to invest directly in Ars Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ars Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ars Pharmaceuticals or SPRY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ars Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ars Pharmaceuticals shares which would translate to 0.076 fractional shares of Ars Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ars Pharmaceuticals, in just a few clicks!

Returns in Ars Pharmaceuticals (SPRY) for Indian investors in Rupees

The Ars Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ars Pharmaceuticals investment value today

Current value as on today

₹1,41,690

Returns

₹41,690

(+41.69%)

Returns from Ars Pharmaceuticals Stock

₹36,288 (+36.29%)

Dollar Returns

₹5,402 (+5.4%)

Indian investors sentiment towards Ars Pharmaceuticals (SPRY)

60%

Period: Feb 9, 2025 to Mar 11, 2025. Change in 30 Days versus previous period

Search interest for Ars Pharmaceuticals Stock from India on INDmoney has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Ars Pharmaceuticals

  • RA Capital Management, LLC

    11.18%

  • Deerfield Management Co

    10.82%

  • Orbimed Advisors, LLC

    8.53%

  • BlackRock Inc

    4.71%

  • SR ONE CAPITAL MANAGEMENT, LP

    4.13%

  • AllianceBernstein L.P.

    3.99%

Analyst Recommendation on Ars Pharmaceuticals

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Ars Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
6
Hold
1
1
3
Sell
0
0
0

Analyst Forecast on Ars Pharmaceuticals Stock (SPRY)

What analysts predicted

Upside of 158.46%

Target:

$29.80

Current:

$11.53

Insights on Ars Pharmaceuticals Stock (Ticker Symbol: SPRY)

  • Price Movement

    In the last 7 days, SPRY stock has moved up by 6.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, -30.0K → 2.06M (in $), with an average increase of 90.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -7.16M → -19.12M (in $), with an average decrease of 39.3% per quarter
  • SPRY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 26.5%
  • Price to Sales

    ForSPRY every $1 of sales, investors are willing to pay $427.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.6 for every $1 of sales.

Ars Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ars Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Ars Pharmaceuticals (SPRY) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ars Pharmaceuticals Inc logo
-1.79%
-3.92%
36.29%
220.28%
-53.88%
Regeneron Pharmaceuticals, Inc. logo
4.03%
-37.08%
-26.01%
9.41%
54.26%
Beone Medicines Ltd logo
11.85%
16.37%
50.05%
67.46%
69.92%
Vertex Pharmaceuticals Incorporated logo
3.91%
2.86%
18.4%
102.06%
121.11%
Alnylam Pharmaceuticals, Inc. logo
-12.89%
-8.85%
62.8%
57.27%
135.05%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ars Pharmaceuticals Inc logo
NA
NA
NA
-0.56
-0.22
-0.16
NA
2.07
Regeneron Pharmaceuticals, Inc. logo
18.45
18.45
1.04
42.83
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.42
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ars Pharmaceuticals Inc logo
Buy
$1.1B
-53.88%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$80.1B
54.26%
18.45
31.07%
Beone Medicines Ltd logo
NA
$27.4B
69.92%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$125.4B
121.11%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.6B
135.05%
NA
-12.37%

About Ars Pharmaceuticals

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Organization
Ars Pharmaceuticals
Employees
23
CEO
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Industry
Healthcare

Management People of Ars Pharmaceuticals

NameTitle
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Founder, President, CEO & Director
Dr. Sarina Tanimoto M.B.A., M.D.
Co-Founder & Chief Medical Officer
Mr. Alexander A. Fitzpatrick Esq.
Chief Legal Officer & Secretary
Dr. Robert Bell Ph.D.
Co-Founder & Chief Science Officer
Ms. Kathleen D. Scott CPA
Chief Financial Officer
Mr. Brian T. Dorsey M.S.
Chief Operations Officer
Mr. Daniel Relovsky
Senior Vice President of Marketing
Mr. Harris Kaplan M.B.A.
Executive Vice President of Commercial Strategy
Mr. Eric Karas
Chief Commercial Officer
Mr. Justin Chakma
Chief Business Officer & Secretary

Important FAQs about investing in SPRY Stock from India :

What is Ars Pharmaceuticals share price today?

Ars Pharmaceuticals share price today stands at $11.53, Open: $10.80 ; Previous Close: $10.83 ; High: $11.62 ; Low: $10.70 ; 52 Week High: $18.51 ; 52 Week Low: $7.55.

The stock opens at $10.80, after a previous close of $10.83. The stock reached a daily high of $11.62 and a low of $10.70, with a 52-week high of $18.51 and a 52-week low of $7.55.

Can Indians buy Ars Pharmaceuticals shares?

Yes, Indians can invest in the Ars Pharmaceuticals (SPRY) from India.

With INDmoney, you can buy Ars Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ars Pharmaceuticals at zero transaction cost.

How can I buy Ars Pharmaceuticals shares from India?

It is very easy to buy Ars Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ars Pharmaceuticals (SPRY) be purchased?

Yes, you can buy fractional shares of Ars Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ars Pharmaceuticals stocks?

To start investing in Ars Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ars Pharmaceuticals Stock (SPRY)?

Today’s highest price of Ars Pharmaceuticals (SPRY) is $11.62.

Today’s lowest price of Ars Pharmaceuticals (SPRY) is $10.70.

What is today's market capitalisation of Ars Pharmaceuticals?

Today's market capitalisation of Ars Pharmaceuticals SPRY is 1.1B

What is the 52 Week High and Low Range of Ars Pharmaceuticals Stock (SPRY)?

  • 52 Week High

    $18.51

  • 52 Week Low

    $7.55

What are the historical returns of Ars Pharmaceuticals (SPRY)?

  • 1 Month Returns

    -1.79%

  • 3 Months Returns

    -3.92%

  • 1 Year Returns

    36.29%

  • 5 Years Returns

    -53.88%

Who is the Chief Executive Officer (CEO) of Ars Pharmaceuticals ?

Mr. Richard Lowenthal M.B.A., M.S., MSMSEL is the current Chief Executive Officer (CEO) of Ars Pharmaceuticals.